Low molecular weight heparin (enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit (Q47430660)

16 January 2018

title

Low molecular weight heparin (enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit (English)

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

9 December 2022

0 references

1 reference

internal iliac artery

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849930

9 December 2022

balloon angioplasty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849930

Cardiology and cardiovascular medicine

9 December 2022

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

9 December 2022

author name string

J. W. Currier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849930

9 December 2022

T. K. Pow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849930

9 December 2022

C. C. Haudenschild

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849930

9 December 2022

A. C. Minihan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849930

9 December 2022

D. P. Faxon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849930

9 December 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

16 January 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0735109791909478?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

https://api.elsevier.com/content/article/PII:0735109791909478?httpAccept=text/plain

9 December 2022

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Journal of the American College of Cardiology

9 December 2022

published in

1 reference

16 January 2018

volume

17

1 reference

16 January 2018

issue

6 Suppl B

1 reference

16 January 2018

page(s)

118B-125B

1 reference

16 January 2018

Medical approaches to prevention of restenosis after coronary angioplasty

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Mechanism of angioplasty and its relation to restenosis

9 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

9 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study

9 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty

9 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty

9 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty

9 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Randomised trial of fish oil for prevention of restenosis after coronary angioplasty

9 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty

9 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids

9 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit

9 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Acute effects of transluminal angioplasty in three experimental models of atherosclerosis

9 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Effect of antiplatelet therapy on restenosis after experimental angioplasty

9 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Restenosis following transluminal angioplasty in experimental atherosclerosis

9 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty

9 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty

9 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Coronary artery thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty: improving results

9 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor

9 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

9 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Suppression by heparin of smooth muscle cell proliferation in injured arteries

9 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth

9 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Heparin inhibition of smooth muscle cell proliferation: a cellular site of action

9 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration

9 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Significance of quiescent smooth muscle migration in the injured rat carotid artery

9 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies

9 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin

9 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Effect of heparin on vascular smooth muscle cells. I. Cell metabolism

9 December 2022

36

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Heparin regulates smooth muscle S phase entry in the injured rat carotid artery

9 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

9 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury

9 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty

9 December 2022

40

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90947-8

9 December 2022

Identifiers

1 reference

16 January 2018

1 reference

16 January 2018